A matching‐adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia
Adam S. Kittai, Alan P Skarbnik, Miguel Miranda, Alan SM Yong, Jack Roos, Robert Hettle, Sarah Palazuelos‐Munoz, Vikram Shetty, Paolo Ghia
Abstract
Video Abstract
Topics & Concepts
Chronic lymphocytic leukemiaRefractory (planetary science)MedicineOncologyInternal medicineCancer researchLeukemiaBiologyAstrobiologyChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsLymphoma Diagnosis and Treatment